This Article is no longer available, this page is showing similar articles.

Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Industry Victory: Texas Food Additive Labeling Law Put On Ice

An unusual lineup of states is jumping on board the Trump administration's "Make America Healthy Again" campaign. There are currently dozens of pending bills in state legislatures seeking to ban certain consumable...

United States Healthcare

FB

FBT Gibbons

Top 10 Takeaways On FCA Enforcement From The FBA's 2026 Qui Tam Conference

The Federal Bar Association's 2026 Qui Tam Conference featured two sets of remarks from Deputy Assistant Attorney General of the U.S. Department of Justice's (DOJ) Commercial Litigation Branch, Brenna Jenny (DAAG Jenny).

United States Healthcare

M

Mintz

Urgent-Care Management Company-affiliated Lab Arrangement Clears AKS Scrutiny

The Health and Human Services Office of Inspector General (HHS-OIG) recently issued a favorable advisory opinion (AO-26-02) stating that it would not sanction an urgent-care...

United States Healthcare

BS

Butler Snow LLP

FDA Issues Draft Guidance On Using The "Plausible Mechanism" Framework To Develop Individualized Therapies For Rare Genetic Diseases

On February 23, 2026, the U.S. Food and Drug Administration released its Draft Guidance for Industry, "Considerations for the Use of Plausible Mechanism Framework to Develop Individualized Therapies that Target Specific Genetic Conditions with Known Biological Cause".

United States Healthcare

FL

Foley & Lardner

UK PMCPA Publishes Revised Guidance For The Use Of Social Media

United States Healthcare

AP

Arnold & Porter

The Long Tail Of The Opioid Crisis: How AGs Continue To Pursue Manufacturers, Distributors, Pharmacies

United States Healthcare

B

Benesch Friedlander Coplan & Aronoff LLP

The February 2026 Compliance Deadline Is Here: Practical Steps For Substance Use Disorder Information Privacy Compliance

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

Insurance Executives Sentenced To 20 Years For $233 Million ACA Enrollment Fraud Scheme

United States Healthcare

AF

ArentFox Schiff

FDA In Flux — February 2026 Newsletter

United States Healthcare

M

Mintz

FDA Approves Accord's FILKRI (Filgrastim-laha), A Biosimilar To NEUPOGEN

United States Healthcare

GP

Goodwin Procter LLP

Health-e Law Episode 21. J.P. Morgan Healthcare 2026 And Beyond: Technology Adoption And Strategic Transformation Under Cost Pressure (Podcast)

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

HHS OIG Releases New Medicare Advantage Compliance Program Guidance

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

New Oral Polio Vaccine Type 2 (NOPV2) Prequalified By WHO

Worldwide Healthcare

GP

Goodwin Procter LLP

HRSA Requests Comments On Future 340B Rebate Model Development

United States Healthcare

SR

McDermott Will & Schulte

See more

Webinars

See More

Recorded on 20 Jan 2026 | 3:00 PM

2026 Canadian In-House Counsel Report: Unparalleled Insights into Canada's In-House Profession from CBA In-House Lawyers

TC

CBA In-House Lawyers

Recorded on 24 Jun 2025 | 3:00 PM

(2nd Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 24 Jun 2025 | 9:00 AM

(1st Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 30 Apr 2025 | 2:00 PM

Mondaq | 2025 Law Firm Data Landscape Report

mm

Mondaq

Highlighted Content

Plausibility At The EPO – An Update On G2/21

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

How Good Does A Copy Need To Be?

United States Healthcare

D

Dehns

Supplementary Protection Certificates – European Patent Term Extensions

United States Healthcare

D

Dehns

How Much Experimental Data Is Needed For Patent Applications In Europe?

United States Healthcare

D

Dehns

The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

United States Healthcare

D

Dehns

Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector

United States Healthcare

D

Dehns

Protection For Plant Varieties In Europe And The UK Post-Brexit

United States Healthcare

D

Dehns

Best Practice For Invention Harvesting

United States Healthcare

D

Dehns

Life Sciences, Biotechnology & Nanotechnology

Privacy Legislation In Texas: What Happened In 2025 And What's Next

In 2025, Texas demonstrated its intention to be an aggressive privacy legislator and regulator...

United States Privacy

HK

Holland & Knight

UK PMCPA Publishes Revised Guidance For The Use Of Social Media

The Prescription Medicines Code of Practice Authority (PMCPA) has published revised guidance on social media.

United States Healthcare

AP

Arnold & Porter

FDA In Flux — February 2026 Newsletter

Welcome to FDA in Flux — A Mintz newsletter tracking rapid changes in policy and agency actions that impact medical, life sciences, and consumer product investment decisions and development strategies.

United States Healthcare

M

Mintz

Formycon And Lotus Expand Collaboration In Asia-Pacific Region To Pembrolizumab Biosimilar

United States Healthcare

GP

Goodwin Procter LLP

Celebrating Black History Month -- Dr. Charles Drew, The Doctor Who Revolutionized Blood Storage

United States Employment

CL

Cowan Liebowitz & Latman PC

Trump Administration Pursues MFN Pricing For Prescription Drugs

United States Healthcare

CM

Crowell & Moring LLP

Senate HELP Committee Releases FDA Modernization Report: "Patients And Families First: Building The FDA Of The Future"

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

CDMO Platforms Will Be The Central Arena For MedTech M&A In 2026

United States Healthcare

AM

Alvarez & Marsal

Iowa Asks Eighth Circuit To Unblock Key Pharmacy Benefit Manager Reform Law Provisions

United States Healthcare

DM

Duane Morris LLP

See more

Healthcare

Federal Court Rules Documents Prepared Using Public AI Tools Not Protected By Attorney-Client Privilege

The case involves Bradley Heppner, the former CEO of Beneficient, a Texas-based financial services company. Federal prosecutors have charged Heppner with fraud in connection with an alleged scheme...

United States Technology

BT

Barnes & Thornburg LLP

Privacy Legislation In Texas: What Happened In 2025 And What's Next

In 2025, Texas demonstrated its intention to be an aggressive privacy legislator and regulator...

United States Privacy

HK

Holland & Knight

Top 10 Takeaways On FCA Enforcement From The FBA's 2026 Qui Tam Conference

The Federal Bar Association's 2026 Qui Tam Conference featured two sets of remarks from Deputy Assistant Attorney General of the U.S. Department of Justice's (DOJ) Commercial Litigation Branch, Brenna Jenny (DAAG Jenny).

United States Healthcare

M

Mintz

Urgent-Care Management Company-affiliated Lab Arrangement Clears AKS Scrutiny

United States Healthcare

BS

Butler Snow LLP

UK PMCPA Publishes Revised Guidance For The Use Of Social Media

United States Healthcare

AP

Arnold & Porter

The February 2026 Compliance Deadline Is Here: Practical Steps For Substance Use Disorder Information Privacy Compliance

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

Justice Department Sues OhioHealth For Restrictive All-or-Nothing Insurance Contracting Provisions

United States Anti-trust

M

Mintz

Insurance Executives Sentenced To 20 Years For $233 Million ACA Enrollment Fraud Scheme

United States Healthcare

AF

ArentFox Schiff

FDA In Flux — February 2026 Newsletter

United States Healthcare

M

Mintz

See more

Food and Drugs Law

Industry Victory: Texas Food Additive Labeling Law Put On Ice

An unusual lineup of states is jumping on board the Trump administration's "Make America Healthy Again" campaign. There are currently dozens of pending bills in state legislatures seeking to ban certain consumable...

United States Healthcare

FB

FBT Gibbons

FDA Issues Draft Guidance On Using The "Plausible Mechanism" Framework To Develop Individualized Therapies For Rare Genetic Diseases

On February 23, 2026, the U.S. Food and Drug Administration released its Draft Guidance for Industry, "Considerations for the Use of Plausible Mechanism Framework to Develop Individualized Therapies that Target Specific Genetic Conditions with Known Biological Cause".

United States Healthcare

FL

Foley & Lardner

Tax Law Increasingly Subject To Administrative And Constitutional Law

Of the many legal trends influencing tax law, arguably none could prove more significant than the growing importance of constitutional and administrative law principles limiting executive power.

United States Tax

SA

Skadden Arps Slate Meagher & Flom

The Long Tail Of The Opioid Crisis: How AGs Continue To Pursue Manufacturers, Distributors, Pharmacies

United States Healthcare

B

Benesch Friedlander Coplan & Aronoff LLP

FDA In Flux — February 2026 Newsletter

United States Healthcare

M

Mintz

FDA Approves Accord's FILKRI (Filgrastim-laha), A Biosimilar To NEUPOGEN

United States Healthcare

GP

Goodwin Procter LLP

SCOTUS Disarms President Trump In Trade War, Scrapping Tariff Authority

Worldwide International

BS

Ballard Spahr LLP

New Oral Polio Vaccine Type 2 (NOPV2) Prequalified By WHO

Worldwide Healthcare

GP

Goodwin Procter LLP

Supreme Court Strikes Down IEEPA Tariffs; Refund Process To Be Determined

United States International

GP

Goodwin Procter LLP

See more

Latest Videos

See more

Leaders In Law: Life Sciences And Technology Transactions With Jekkie Kim (Podcast)

W

WilmerHale

Digging Into New York's New Price-Gouging Rules (Video)

BS

Bond, Schoeneck & King PLLC

Pay Transparency + The Power Of Preventive Strategies: Episode 3 — Pivoting Toward Preparation In The Life Sciences (Video)

JL

Jackson Lewis P.C.

Scaling Virtual Care: Dr. Pribitkin's Framework For The Future (Video)

AM

Alvarez & Marsal

Episode 37: Chanda Center For Health: Reimagining Access To And Delivery Of Long-term Disability Care (Podcast)

FL

Foley & Lardner

Upcoming Events

Healthcare Regulatory & Compliance Summit

United States Healthcare

BB

Bass, Berry & Sims

Reception During 2026 Expo West

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

A Collective Force: When Women Leaders Gather

United States Healthcare

FH

Foley Hoag LLP

Hot Topics In Advertising Law: The NAD And Drug And Medical Device Promotion

United States Healthcare

AP

Arnold & Porter

Institute On Medicare And Medicaid Payment Issues

United States Healthcare

FL

Foley & Lardner

DC Health Innovation Summit 2026: Healthcare & Life Sciences

United States Healthcare

FH

Foley Hoag LLP

Virtual Forty-Third National HIPAA Summit

United States Healthcare

HK

Holland & Knight

Women Future Forward

United States Healthcare

FH

Foley Hoag LLP

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More